HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Levodopa → Carbidopa

HRID 452338
Print

Reaction equation

HRID 452338 reaction equation
C1C(C[C@H](N)C(O)=O)=CC(O)=C(O)C=1.C1C(C[C@H](N)C(O)=O)=CC(O)=C(O)C=1.[CH3:29][C@@:30]([NH:43][NH2:44])([C:40]([OH:42])=[O:41])[CH2:31][C:32]1[CH:33]=[CH:34][C:35]([OH:39])=[C:36]([OH:38])[CH:37]=1>>[CH3:29][C@@:30]([NH:43][NH2:44])([C:40]([OH:42])=[O:41])[CH2:31][C:32]1[CH:33]=[CH:34][C:35]([OH:39])=[C:36]([OH:38])[CH:37]=1
ParticipantsProcedureSources & evidenceReaction notes

Participants

3

Reactant 2

HCID 6047LevodopaHCID 104778Carbidopa-levodopa mixt.

Product 1

HCID 34359Carbidopa

Procedure

The in vitro dissolution profile of levodopa-carbidopa extended release capsules (from Example 3E), containing 200 mg levodopa and 50 mg carbidopa was obtained under simulated gastric conditions. The dissolution tests were performed in 900 mL of a 0.1 N HCl-pH 1.2 solution in a USP II apparatus at a temperature of 37° C. The paddle speed was set at 50 rpm. Samples of dissolution media were collected at predetermined intervals and analyzed by HPLC. The dissolution profiles of levodopa and carbidopa obtained from HPLC analysis are shown in FIG. 13.

Sources & evidence

ORD record
ord-63192a2fe1f54bafafb08780368c4579
Source dataset
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08491929B2

Reaction notes

On this pageParticipantsProcedureSources & evidenceReaction notes